Physician profile
Michael J Coyle
NPI 1548268246
$15,932.06
in general payments reported to CMS, 2019-2025
15 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $268 · 2021: $2,478 · 2022: $624 · 2023: $125 · 2024: $675 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760 · Gift: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.74 |
| Gift | $189.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,577.23 | 2019-2024 | |
| Medtronic, INC. | $897.85 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $561.04 | 2019-2024 | Veozah |
| Coloplast Corp | $436.17 | 2019-2022 | |
| Medtronic USA, INC. | $82.04 | 2019-2020 | |
| Medical Device Business Services, INC. | $74.82 | 2021 | |
| Baxter Healthcare | $61.04 | 2021 | |
| Hologic Sales and Service, LLC | $60.72 | 2020 | |
| Mission Pharmacal Company | $39.43 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.81 | 2019 | |
| Abbvie INC. | $31.56 | 2020-2022 | |
| Allergan, INC. | $30.29 | 2021 | |
| Urovant Sciences INC | $20.76 | 2022 | |
| Duchesnay USA Incorporated | $13.87 | 2019 | |
| Ethicon US, LLC | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.